Operating Lease, Right-of-Use Asset of VYNE Therapeutics Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
VYNE Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • VYNE Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

VYNE Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $0 -$93,000 -100% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q2 2025 $32,000 -$119,000 -79% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $62,000 -$118,000 -66% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $93,000 -$114,000 -55% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $122,000 +$122,000 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $151,000 +$151,000 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $180,000 +$180,000 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $207,000 +$207,000 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $0 $0 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $0 $0 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $0 $0 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $0 $0 31 Dec 2022 10-K 01 Mar 2024 2023 FY
Q3 2022 $0 -$1,036,000 -100% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $0 -$1,225,000 -100% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $0 -$1,407,000 -100% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $0 -$1,583,000 -100% 31 Dec 2021 10-K 17 Mar 2022 2021 FY
Q3 2021 $1,036,000 -$1,155,000 -53% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $1,225,000 -$1,333,000 -52% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $1,407,000 -$314,000 -18% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $1,583,000 -$111,000 -6.6% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 $2,191,000 +$1,361,000 +164% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $2,558,000 +$1,573,000 +160% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $1,721,000 +$1,051,000 +157% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $1,694,000 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 $830,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $985,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $670,000 31 Mar 2019 10-Q 02 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.